PASSIFLORA INCARNATA FLOWERING TOP and DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS

6 reports of this reaction

2.7% of all PASSIFLORA INCARNATA FLOWERING TOP reports

#5 most reported adverse reaction

Overview

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is the #5 most commonly reported adverse reaction for PASSIFLORA INCARNATA FLOWERING TOP, manufactured by Boiron. There are 6 FDA adverse event reports linking PASSIFLORA INCARNATA FLOWERING TOP to DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS. This represents approximately 2.7% of all 226 adverse event reports for this drug.

Patients taking PASSIFLORA INCARNATA FLOWERING TOP who experience drug reaction with eosinophilia and systemic symptoms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS6 of 226 reports

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS is a less commonly reported adverse event for PASSIFLORA INCARNATA FLOWERING TOP, but still significant enough to appear in the safety profile.

Other Side Effects of PASSIFLORA INCARNATA FLOWERING TOP

In addition to drug reaction with eosinophilia and systemic symptoms, the following adverse reactions have been reported for PASSIFLORA INCARNATA FLOWERING TOP:

Other Drugs Associated with DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS

The following drugs have also been linked to drug reaction with eosinophilia and systemic symptoms in FDA adverse event reports:

CEFTRIAXONECEFTRIAXONE SODIUMCISATRACURIUM BESYLATEDAPSONEDAPSONE GEL, 5%DAPTOMYCINDASPONEISONIAZIDLYTTA VESICATORIAMEROPENEMPHENYTOINPHENYTOIN SODIUMPIPERACILLIN AND TAZOBACTAMPIPERACILLIN SODIUM,TAZOBACTAM SODIUMPYRAZINAMIDERIFAMPINVANCOMYCINVANCOMYCIN HYDROCHLORIDE

Frequently Asked Questions

Does PASSIFLORA INCARNATA FLOWERING TOP cause DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS?

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS has been reported as an adverse event in 6 FDA reports for PASSIFLORA INCARNATA FLOWERING TOP. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS with PASSIFLORA INCARNATA FLOWERING TOP?

DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS accounts for approximately 2.7% of all adverse event reports for PASSIFLORA INCARNATA FLOWERING TOP, making it a notable side effect.

What should I do if I experience DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS while taking PASSIFLORA INCARNATA FLOWERING TOP?

If you experience drug reaction with eosinophilia and systemic symptoms while taking PASSIFLORA INCARNATA FLOWERING TOP, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

PASSIFLORA INCARNATA FLOWERING TOP Full ProfileAll Drugs Causing DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMSBoiron Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.